Search research articles
Contact Us
Filters
Showing results (841-850 of 1,044) with videos related to
Page
of 105
Sort By:
Physical Chemistry Chemical Physics : PCCP
|
November 23, 2017
UV-Vis spectrophotometry of quinone flow battery electrolyte for in situ monitoring and improved electrochemical modeling of potential and quinhydrone formation
Liuchuan Tong, Qing Chen, Andrew A Wong, et al.
European Journal of Clinical Investigation
|
October 1, 1992
Transforming growth factor alpha and atrial natriuretic peptide in white adipose tissue depots in rats
D L Crandall, G Gordon, H E Herzlinger, et al.
Cancer Research
|
December 1, 1986
Cancer procoagulant in human tumor cells: evidence from melanoma patients
M B Donati, C Gambacorti-Passerini, B Casali, et al.
The British Journal of Surgery
|
November 8, 2011
Healthcare resource use and medical costs for the management of oesophageal cancer
L G Gordon, S Eckermann, N G Hirst, et al.
Applied Optics
|
June 26, 2010
Combined optical second harmonic generation/quartz crystal microbalance study of underpotential deposition processes: copper electrodeposition on polycrystalline gold
S Lakkaraju, M J Bennahmias, G L Borges, et al.
Breast Cancer (Tokyo, Japan)
|
December 3, 2022
A cost-consequences analysis of the SAFE trial: a comparative, effectiveness trial evaluating high- versus low-supervision of an exercise intervention for women with breast cancer
Jessica T Watzek, Louisa G Gordon, Carolina X Sandler, et al.
Gynecologic Oncology
|
December 21, 2010
Hospital costs associated with adverse events in gynecological oncology
Srinivas Kondalsamy-Chennakesavan, Louisa G Gordon, Karen Sanday, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 18, 2017
What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?
Merehau C Mervin, Anthony Lowe, Robert A Gardiner, et al.
Prenatal Diagnosis
|
November 3, 2017
Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis
Louisa G Gordon, Catherine A Hyland, Jonathan A Hyett, et al.
Urologic Oncology
|
November 25, 2017
Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis
Louisa G Gordon, Haitham W Tuffaha, Robbie James, et al.
Page
of 105
Search research articles
Search
Showing results (841-850 of 1,044) with videos related to
Sort By:
Page
of 105
Physical Chemistry Chemical Physics : PCCP
|
November 23, 2017
UV-Vis spectrophotometry of quinone flow battery electrolyte for in situ monitoring and improved electrochemical modeling of potential and quinhydrone formation
Liuchuan Tong, Qing Chen, Andrew A Wong, et al.
European Journal of Clinical Investigation
|
October 1, 1992
Transforming growth factor alpha and atrial natriuretic peptide in white adipose tissue depots in rats
D L Crandall, G Gordon, H E Herzlinger, et al.
Cancer Research
|
December 1, 1986
Cancer procoagulant in human tumor cells: evidence from melanoma patients
M B Donati, C Gambacorti-Passerini, B Casali, et al.
The British Journal of Surgery
|
November 8, 2011
Healthcare resource use and medical costs for the management of oesophageal cancer
L G Gordon, S Eckermann, N G Hirst, et al.
Applied Optics
|
June 26, 2010
Combined optical second harmonic generation/quartz crystal microbalance study of underpotential deposition processes: copper electrodeposition on polycrystalline gold
S Lakkaraju, M J Bennahmias, G L Borges, et al.
Breast Cancer (Tokyo, Japan)
|
December 3, 2022
A cost-consequences analysis of the SAFE trial: a comparative, effectiveness trial evaluating high- versus low-supervision of an exercise intervention for women with breast cancer
Jessica T Watzek, Louisa G Gordon, Carolina X Sandler, et al.
Gynecologic Oncology
|
December 21, 2010
Hospital costs associated with adverse events in gynecological oncology
Srinivas Kondalsamy-Chennakesavan, Louisa G Gordon, Karen Sanday, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 18, 2017
What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?
Merehau C Mervin, Anthony Lowe, Robert A Gardiner, et al.
Prenatal Diagnosis
|
November 3, 2017
Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis
Louisa G Gordon, Catherine A Hyland, Jonathan A Hyett, et al.
Urologic Oncology
|
November 25, 2017
Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis
Louisa G Gordon, Haitham W Tuffaha, Robbie James, et al.
Page
of 105